Sandbox:staging: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Neuroblastoma Staging== ===International Neuroblastoma Staging System (INSS)=== The staging of neuroblastoma is based on the International Neuroblastoma Staging System (INSS...") |
mNo edit summary |
||
Line 78: | Line 78: | ||
==Risk Stratification== | ==Risk Stratification== | ||
* Neuroblastoma patients are risk stratified into a low risk group, an intermediate risk group, and a high risk group based on the [[tumor]] INSS stage, the patient's age, and the tumor | * Neuroblastoma patients are risk stratified into a low risk group, an intermediate risk group, and a high risk group based on the [[tumor]] INSS stage, tumor grade the patient's age, and the molecular pathway involved. | ||
* '''Low risk neuroblastoma groups''' include: | |||
:* Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway. | |||
:* Patients with stage 2A/2B, irrespective of age, irrespective of grade, MYCN-NA molecular pathway | |||
:* Patients with Stage 4S, <365 days of age, favorable histology, DNA Index >1 , MYCN-NA molecular pathway | |||
* '''Intermediate risk neuroblastoma groups''' include: | |||
:* Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway. |
Revision as of 13:44, 7 October 2015
Neuroblastoma Staging
International Neuroblastoma Staging System (INSS)
The staging of neuroblastoma is based on the International Neuroblastoma Staging System (INSS).[1]
T | Description |
Stage 1 |
|
Stage 2A |
|
Stage 2B |
|
Stage 3 |
|
Stage 4 |
|
Stage 4S |
|
International Neuroblastoma Risk Group Staging System (INRGSS)
Stage: | Description |
Stage L1 |
|
Stage L2 |
|
Stage M |
|
Stage MS |
|
Risk Stratification
- Neuroblastoma patients are risk stratified into a low risk group, an intermediate risk group, and a high risk group based on the tumor INSS stage, tumor grade the patient's age, and the molecular pathway involved.
- Low risk neuroblastoma groups include:
- Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway.
- Patients with stage 2A/2B, irrespective of age, irrespective of grade, MYCN-NA molecular pathway
- Patients with Stage 4S, <365 days of age, favorable histology, DNA Index >1 , MYCN-NA molecular pathway
- Intermediate risk neuroblastoma groups include:
- Patients with stage 1 tumor irrespective of the age, grade, and molecular pathway.
- ↑ Neuroblastoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Neuroblastoma Accessed on October, 5 2015